Webcast: Crinetics Pharmaceuticals to Report Second Quarter 2026 Financial Results
Event Date: Event Date: August 4, 2026
Read MoreWebcast: Crinetics Pharmaceuticals to Report First Quarter 2026 Financial Results
Event Date: Event Date: May 7, 2026
Read MoreWebcast: Crinetics Pharmaceuticals Corporate Update
Event Date: Crinetics Pharmaceuticals will host a conference call and webcast on Monday, January 5, 2026 at 8:30 a.m. ET to provide an update on PALSONIFY™ (paltusotine) commercialization and disclose topline results from the fourth cohort of the Phase 2 trial of atumelnant in congenital adrenal hyperplasia.
Read MoreWebcast: Crinetics Pharmaceuticals Presentation at the 44th Annual J.P. Morgan Healthcare Conference
Event Date: Scott Struthers, Ph.D., Founder and Chief Executive Officer of Crinetics, will present at the 44th Annual J.P. Morgan Healthcare Conference being held in San Francisco, CA on Tuesday, January 13, 2026 at 9:45 a.m. Pacific Time.
Read MoreWebcast: Crinetics to Report Fourth Quarter and Full Year 2025 Financial Results
Event Date: Event Date: February 26, 2026
Read MoreCrinetics to Participate in TD Cowen 46 Annual Health Care Conference
Event Date: Event Date: March 4, 2026
Read MoreWebcast: Crinetics Pharmaceuticals to Report Third Quarter 2025 Financial Results
Event Date: Crinetics company management will report third quarter 2025 financial results on Thursday, November 6, 2025 after the market closes.
Read MoreFDA Approval of PALSONIFY™ (paltusotine) for the Treatment of Adults with Acromegaly
Event Date: Crinetics will host an investor conference call on September 25, at 6:00 pm Eastern Time to discuss the FDA approval of PALSONIFY. Live & Archived Webcast: https://events.q4inc.com/attendee/443074040 Dial-in Details: Domestic: 1-833-470-1428International: 1-646-844-6383Conference ID: 120796
Read MoreWebcast: Crinetics Pharmaceuticals to Report Second Quarter 2025 Financial Results
Event Date: August 7, 2025
Read More